-
Follow the Money: Single-Cell Multiomics, Data Networks, Security
Bio-IT World | New investment funds for late-stage companies and public health. Next-gen genomic medicines and single-cell multiomics get cash, and PatientsLikeMe raises a new round of funding to expand.
Apr 1, 2021
-
Viruses (And People) Play A ‘Signaling Game’ With Strangers And Dangers
Bio-IT World | Mathematically speaking, the cytokine storm seen with severe COVID-19 and the out-of-control behavior of QAnon conspiracy theorists are not really all that different, according to Bud Mishra, a professor at New York University's Courant Institute of Mathematical Sciences. Both invoke a stranger-danger “signaling game” that would also explain how messenger RNA (mRNA) and transfer RNA (tRNA) came to be cellular co-occupants some three and half billion years ago.
Mar 31, 2021
-
Global Research Spanning 30+ Countries to Examine COVID’s Impact on the Brain
Bio-IT World | While it isn’t clear just yet how the coronavirus could impact cognition over the long haul, a global group of researchers is looking to learn more.
Mar 30, 2021
-
5 Important AI Discoveries Generated by COVID-19
Bio-IT World | Life sciences leaders are outlining the learnings from COVID-19 to move forward, hopefully stronger, wiser, and better than before.
Mar 26, 2021
-
New Framework For Developing Polygenic Risk Scores
Bio-IT World | Last week a research team published a 22-item framework in Nature that identifies the minimal polygenic risk score-related information that scientists should include in their studies.
Mar 25, 2021
-
Eric Dishman on Paul Allen, Andy Grove, and All of Us
Bio-IT World | TRENDS FROM THE TRENCHES—It’s been a little over a year since Eric Dishman stepped down as CEO of the National Institutes of Health’s All of Us program and took on the role of Chief Innovation Officer. Now he talks about his early training under Paul Allen of Microsoft and Andy Grove of Intel still plays into his decisions.
Mar 23, 2021


